Jw. Langston et al., Novel alpha-synuclein-immunoreactive proteins in brain samples from the Contursi kindred, Parkinson's, and Alzheimer's disease, EXP NEUROL, 154(2), 1998, pp. 684-690
A specific mutation (A53T) in the encoding region for alpha-synuclein has b
een identified in a large multigenerational family with an autosomal domina
nt parkinsonism known as the Contursi kindred. In this study, we used a mon
oclonal antibody directed against alpha-synuclein in order to identify nove
l proteins in the brain of an affected member of this kindred who had come
to autopsy. Homogenates from the frontal cortex and caudate nucleus were ex
amined using Western blot techniques and compared to matched autopsy specim
ens from control subjects and patients with various forms of parkinsonism.
Western blots, using a 15-min exposure time, revealed the expected 19-kDa b
and representing alpha-synuclein in all brain samples examined. However, a
novel band in the 36-kDa range was also present in the Contursi brain which
was not seen in cortex or caudate from control brains or in frontal cortex
hom 14 cases of typical Parkinson's disease. With a 24-h exposure time, th
is band was faintly seen in the caudate nucleus of three of the Parkinson's
disease cases. Surprisingly the 36-kDa band (as well as other high-molecul
ar-weight bands) was also present in frontal cortex and caudate nucleus in
3 additional cases that met diagnostic criteria for both Parkinson's diseas
e and Alzheimer's disease. A preliminary analysis of samples from the front
al cortex of 10 Alzheimer's disease cases revealed a 36-kDa band in only on
e instance. The identification of novel alpha-synuclein-immunoreactive band
s in these various forms of parkinsonism may open new research avenues for
exploring the relationship between abnormal protein deposition in the brain
and one or more neurodegenerative disorders, including the Contursi form o
f familial parkinsonism. (C) 1998 Academic Press.